Patient-centred education for ketamine and esketamine therapies in mood disorders
Therapeutic Advances in Psychopharmacology · 2026-06 · 16
DOI: 10.1177/20451253261456405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 29.06.2026. Verfasst von Zofia Kachlik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, Gdańsk 80-214, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Treatment-resistant depression (TRD) and bipolar depression (TRBD) are severe, heterogeneous mood disorders associated with substantial functional impairment, elevated suicide risk and persistent unmet treatment needs. While pharmacological and psychological interventions continue to advance, many patients experience delayed, partial or unsustained benefit, underscoring the need for therapies with novel mechanisms and rapid onset of action. Ketamine and esketamine have emerged as distinctive treatments in this context, demonstrating rapid antidepressant and anti-suicidal effects, yet differing fundamentally from conventional antidepressants in their acute subjective effects, physiological profile, delivery models and misuse potential. This narrative review synthesizes evidence from regulatory guidance, clinical trials, observational studies and qualitative research to identify key patient information needs and propose practical psychoeducational strategies. Core elements include explanations of indications, mechanisms and treatment algorithms; guidance on visit preparation, scheduling and monitoring; management of acute adverse effects; counselling on suicidality and substance misuse; and tailored considerations for special populations, including older adults, women of reproductive potential and medically complex patients. Drawing on this synthesis, the review proposes a patient-centred framework for ketamine and esketamine psychoeducation, outlining key informational domains and practical tools that can be embedded within clinical services, and identifies priorities for future research aimed at optimizing patient experience and supporting the responsible integration of ketamine-based therapies into mood disorder care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, ul. Smoluchowskiego 17, Gdańsk 80-214, Poland.
- Department of Psychiatry, Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland.
ORCID-Profile: Zofia Kachlik, Michał Walaszek
Zitieren
APA
Kachlik, Z., Cubała, W. J., & Walaszek, M. (2026). Patient-centred education for ketamine and esketamine therapies in mood disorders. Therapeutic Advances in Psychopharmacology, 16. https://doi.org/10.1177/20451253261456405
Vancouver
Kachlik Z, Cubała WJ, Walaszek M. Patient-centred education for ketamine and esketamine therapies in mood disorders. Therapeutic Advances in Psychopharmacology. 2026;16. doi:10.1177/20451253261456405
BibTeX
@article{Kachlik2026,
author = {Kachlik, Zofia and Cubała, Wiesław Jerzy and Walaszek, Michał},
title = {Patient-centred education for ketamine and esketamine therapies in mood disorders},
journal = {Therapeutic Advances in Psychopharmacology},
year = {2026},
volume = {16},
doi = {10.1177/20451253261456405}
}
EUVIMED